Brain metastasis: Prognostic value of the number of involved extracranial organs

Strahlentherapie und Onkologie

Volumn 189, Issue 12, 2013, Pages 996-1000

  Rades, D ^a   Gerdan, L ^a   Segedin, B ^b   Nagy, V ^c   Khoa, M T ^d,e   Trang, N T ^e   Schild, S E ^f  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Institute of Oncology   (Germany)

^c THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^d HANOI MEDICAL UNIVERSITY   (Viet Nam)

^e BACH MAI HOSPITAL   (Viet Nam)

^f MAYO CLINIC   (United States)

Author keywords

Neoplasm metastasis; Number of involved extracranial organs; Prognosis; Survival; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BRAIN RADIATION; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; WHOLE BRAIN RADIOTHERAPY; AGE DISTRIBUTION; BRAIN NEOPLASMS; CARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; EPIDEMIOLOGY; GERMANY; INCIDENCE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; SURVIVAL; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; CARCINOMA; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84890920803     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0442-y     Document Type: Article

References (18)

1. Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672 (Pubitemid 38670323)
2. Dziggel L, Segedin B, Podvrsnik NH et al (2013) Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 189:364-366
3. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751 (Pubitemid 27181303)
4. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
5. Khuntia D, Brown P, Li J et al (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:1295-1304 (Pubitemid 46622033)
6. Komarnicky LT, Phillips TL, Martz K et al (1991) A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 20:53-58
7. Murray KJ, Scott C, Greenberg HM et al (1997) A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39:571-574 (Pubitemid 27441421)
8. Nieder C, Andratschke NH, Geinitz H et al (2012) Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies. Strahlenther Onkol 188:692-695
9. Phillips TL, Scott CB, Leibel SA et al (1995) Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 33:339-348
10. Pitz MW, Musto G, Navaratnam S (2013) Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort. Can Respir J 20:30-34
11. Rades D, Bohlen G, Dunst J et al (2008) Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 184:30-35
12. Rades D, Dunst J, Schild SE (2008) A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 184:251-255 (Pubitemid 351572841)
13. Rades D, Küter JD, Gliemroth J et al (2012) Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Strahlenther Onkol 188:143-147
14. Rades D, Panzner A, Dziggel L et al (2012) Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer 118:3852-3859
15. Sause WT, Scott C, Krisch R et al (1993) Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys 26:653-657 (Pubitemid 23220165)
16. Shimada Y, Saji H, Yoshida K et al (2013) Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest 143:1626-1634
17. Sperduto PW, Berkey B, Gaspar LE et al (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514
18. Wen PY, Black PM, Loeffler JS (2001) Metastatic brain cancer. In: deVita V, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2655-2670